Enovis (NYSE: ENOV) announced today that it has completed its purchase of Novastep and its foot and ankle minimally invasive surgical (MIS) platform. The financial terms of the deal were undisclosed. Novastep generates about $20 million in annual revenue. “We are excited to welcome Novastep’s talented team to Enovis where we will work together to develop […]
Novastep
Enovis to acquire Novastep to expand foot and ankle portfolio
Enovis (NYSE: ENOV) today announced it would acquire Novastep and its foot and ankle minimally invasive surgical (MIS) platform for an undisclosed amount. The transaction is subject to customary conditions and regulatory approvals. It is expected to close in the second quarter of 2023. Novastep generates about $20 million in annual revenue. Its MIS platform, […]
FDA sends warning letters to 12 medical device companies
The FDA today published the warning letters it sent recently to 12 medical device companies in the U.S. and overseas for violations found during recent inspections. The federal safety watchdog’s inspectors found a variety of problems at the companies’ plants, ranging from inadequate design control procedures to problems with the way they track and report adverse […]
